Not Just Another Index.
It’s The New Generation.®
We offer specialized solutions for investors seeking exposure to New Listings - a proxy for economic growth and innovation.
New: The IPOX® High Dividend 7% Strategy
An Innovative Index Strategy
combining Income & Growth!
Upcoming Global IPOs
The IPOX® Newsletters
IPOX® in the News
In a recent Nikkei feature, IPOX® CEO Josef Schuster provided expert commentary on PayPay's $12.1 billion debut on the U.S. Nasdaq. The Japanese smartphone payment giant, backed by SoftBank, aims to leverage its new capital to build a comprehensive digital financial platform. While acknowledging the fierce competition from established U.S. payment giants, Schuster highlighted a unique opportunity for PayPay to fill a void in the market, despite structural concerns regarding the offering's limited share liquidity.
A recent Reuters article covers the highly anticipated $880 million Nasdaq IPO of SoftBank’s digital payment giant, PayPay. Despite global market volatility, the Japanese app successfully debuted with a $10.7 billion valuation. IPOX® Research Associate Lukas Muehlbauer provided commentary on the offering's strategic pricing and the company's unique market position. Muehlbauer highlighted that we are currently in an IPO "buyers' market" and noted that PayPay's dominant domestic strength insulates it from broader geopolitical and macroeconomic concerns.
Reuters covered the Nasdaq debut of Medtronic's diabetes unit, MiniMed, which opened below its offer price amid heightened market volatility. The $5.35 billion listing highlights ongoing challenges in the new issues market. IPOX® Research Associate Lukas Muehlbauer provided expert commentary on the debut, noting that while the offering "shows that the U.S. IPO market is still open," current economic conditions clearly dictate "that it has become a price-sensitive buyers' market."
A recent Bloomberg article highlights the massive outperformance of European defense and aerospace IPOs, which have averaged 87% gains since 2020. Driven by geopolitical tensions and NATO rearmament, this surge in investor demand is prompting a fresh wave of public listings. IPOX® Research Analyst Lukas Muehlbauer provided expert commentary, explaining that ongoing conflicts have created unprecedented backlogs, making IPOs a practical way for defense firms to raise cash and expand capacity.
Reuters highlights SoftBank-backed PayPay’s upcoming $13.4 billion U.S. IPO, a highly anticipated offering expected to boost a volatile listing market. Discussing current market dynamics, IPOX® CEO Josef Schuster noted robust investor appetite is particularly strong for specialty firms across healthcare and select fintech that are insulated from geopolitical and AI-related risks.
The IPOX® Update
The global IPO market is currently heating up with several blockbuster listings in the pipeline. SpaceX is preparing for a record-breaking $50 billion public offering, recently adding Citigroup to its underwriter lineup. In the consumer sector, Roark Capital is weighing a $2 billion IPO for Inspire Brands, the owner of Dunkin'. Meanwhile, Europe anticipates a major boost to the London Stock Exchange as Oaktree Capital Management selects banks for a £2.5 billion listing of wealth management provider Utmost Group Plc.
Elon Musk’s SpaceX is reportedly preparing to confidentially file for a U.S. initial public offering as early as March, aiming for a record-breaking June listing. This highly anticipated share sale could raise up to $50 billion and command a staggering valuation exceeding $1.75 trillion, bolstered by its recent acquisition of the artificial intelligence startup xAI. SpaceX has already aligned major financial institutions, including Bank of America, Goldman Sachs, JPMorgan, and Morgan Stanley, to lead this historic, market-defining public market debut.
The U.S. IPO market faces headwinds as Clear Street and Liftoff Mobile withdraw their listings. IPOX® Associate Lukas Muehlbauer and IPOX® VP Kat Liu noted that AI-driven volatility and crypto declines forced these moves to avoid "failed" IPO stigmas. Meanwhile, Bain Capital explores a $3 billion IPO for Dessert Holdings. In Europe, Thyssenkrupp plans a $13.5 billion materials spin-off, while UI Boustead REIT preps a $788 million Singapore float.